Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.
about
Reflections upon human cancer immune responsiveness to T cell-based therapyInteraction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironmentTopical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanomaMolecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyA systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonistsSystemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Global transcriptional analysis for biomarker discovery and validation in cellular therapies.Immune regulation of cancerConcomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments.Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of conceptGene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.Gene expression profiling of cutaneous wound healing.Potency analysis of cellular therapies: the emerging role of molecular assaysA genetic inference on cancer immune responsivenessThe immunologic aspects of poxvirus oncolytic therapyNew take on comparative immunology: relevance to immunotherapy.Gene-expression profiling in vaccine therapy and immunotherapy for cancerRegression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.Cooperativity of adaptive and innate immunity: implications for cancer therapy.Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancerGM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cellsTopical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancerSignatures associated with rejection or recurrence in HER-2/neu-positive mammary tumorsDendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.Dendritic cell subsets as vectors and targets for improved cancer therapyDendritic cells and immunity against cancer.Immunotherapy in nonmelanoma skin cancer.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Harnessing the immune system for the treatment of melanoma: current status and future prospects.Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.Management of superficial basal cell carcinoma: focus on imiquimod.Analysis of vaccine-induced T cells in humans with cancer.Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells.Turning laboratory findings into therapy: a marathon goal that has to be reached.
P2860
Q27004674-5CB2351D-B0A3-4FE7-A4D2-DC5CF0BD730CQ28389479-012045C3-EB73-4B61-8D6D-1A0450C4D61FQ30276126-54274BDD-4D56-4DD4-8B76-312B885EECFAQ30422102-0F9784BA-3C30-4E64-A5AC-D17C4A1AF96EQ30423599-B86A0C47-1298-49B3-AEBC-27DDEFA53A7AQ30438965-0CCF2605-1B03-4A21-9FCB-3F98B077D6A9Q30440347-5A7F1C25-1531-41D6-9FEB-332F4CD148B7Q33302568-EEA3896B-D995-48B8-A379-2FEAEAC0A2F7Q33479314-F06BB901-8340-4501-BB2C-827C3D144BBCQ34171422-DB50679E-B45C-4B4E-B7AB-FB81938F53F0Q34586327-F51BB2A8-3522-41AB-A4F7-BA4A74CF6B1DQ35047686-B1C65558-8E05-4289-AD08-3C980A40CB20Q35193892-0A551CFC-3CC8-4368-A4B1-90D0BC19F7B9Q35541507-6BECA85C-4904-46BD-8E5E-968A2598E457Q35606746-C8CCBCFE-AE96-4F87-9FDF-359F5AD14F97Q35649056-5F33F772-4FBC-445C-95E5-3F13196F2B4AQ35840586-BBC7B4D1-7B57-4E55-8A0A-A6F804C22046Q36057497-CB87779C-5D6B-4531-8B7F-47D154F09708Q36115128-E1523535-72DE-443B-920B-DFCF9049BC53Q36126352-8ADCBFBF-AB26-4258-B17F-3A5ADC2755CDQ36138329-599524FF-20C8-4343-9806-B534CBABCDC0Q36419244-A6D124AC-9930-4CD6-8B41-6A9A19B31406Q36429508-B06FB63B-9CBB-481B-AB62-A669667FCEDBQ36476394-E6E4A4EA-ABA9-4977-AE2D-47D3A96BD768Q36580172-6928D914-7588-4D9D-873D-276A365BC024Q36632306-C6788A23-EA04-4A8E-A410-E167A84356F0Q36782609-B3ED478D-827B-4B4E-97F1-AA442092D182Q37394755-A6E50577-0A27-4F49-812D-29654393D74CQ37758502-1CC41539-C388-4676-A1C9-97C08B8DF03BQ37821074-08393793-69E2-4E98-9700-9FDC025FA2C8Q38014084-86BE2B08-DF7C-4125-959F-5EF5DD9F686FQ38195656-FD58AFDB-592E-4E80-AE45-C0CEE4E7998EQ38806243-337A99FF-9D85-4008-BE72-5092EB0C0026Q38875037-334EA699-8A08-4212-96E5-D8FA82CD9749Q39705893-3B0A6FA4-BB5B-4F97-81C6-4810A76F5010Q40014321-7DBC00B8-BB7D-4324-A480-8AACA7DBD175Q41272202-733BD3C5-390D-4B8D-A3E4-4744FE52CA77Q42645831-6C3CAFBC-75CE-4C0D-BDD5-FCF3E089E1DFQ54956643-459058B9-C63A-4435-A476-97C138172F73
P2860
Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Sequential gene profiling of b ...... irements for tissue rejection.
@ast
Sequential gene profiling of b ...... irements for tissue rejection.
@en
type
label
Sequential gene profiling of b ...... irements for tissue rejection.
@ast
Sequential gene profiling of b ...... irements for tissue rejection.
@en
prefLabel
Sequential gene profiling of b ...... irements for tissue rejection.
@ast
Sequential gene profiling of b ...... irements for tissue rejection.
@en
P2093
P2860
P356
P1433
P1476
Sequential gene profiling of b ...... irements for tissue rejection.
@en
P2093
Andrea Abati
Armando Filie
Calvin Astry
Christopher Norwood
Eleonora Aricó
Francesco M Marincola
Herbert B Slade
Kina Smith
Mitchell E Stashower
P2860
P2888
P356
10.1186/GB-2007-8-1-R8
P577
2007-01-01T00:00:00Z
P5875
P6179
1021097010